Vascular Graft Solutions
Improving the standard-of-care in cardiovascular surgery
Problem
Coronary artery bypass grafting (CABG) remains the most common cardiac surgery performed today worldwide. However, over 50% of interventions will present vein graft failure in a 10-year timespan post-intervention, leading to complications and the need for re-interventions.
Investment Rationale
Founded in 2009 by serial entrepreneur Dr. Eyal Orion, VGS is the leading developer of innovative technologies to improve surgical re-vascularization, vascular reconstruction procedures, and arteriovenous fistula.
The team knowledge, Eyal capabilities, and market knowledge have allowed the company to bring 4 products to market with limited funding.